Ingredients supplier Solabia acquires majority stake in BioActor
BioActor develops clinically evaluated polyphenol extracts from edible plants and fruits.
Photo © iStockphoto.com
Ingredients supplier Solabia Group (Paris) has acquired a majority stake in BioActor B.V. (Maastricht, the Netherlands), which develops clinically evaluated polyphenol extracts from edible plants and fruits.
A press release states, “Solabia is already present in the nutrition segment through original ingredients recognized for their health benefits, including Algatech’s microalgae-derived active ingredients. This strategic investment will allow Solabia to benefit from a wider range of ingredients and from BioActor’s expertise, strengthening its nutrition division positioning [in] this fast-growing market as customers increasingly look for high-quality active ingredients that combine naturality with proof of efficacy.”
BioActor will continue to focus on R&D and product development, with the companies stating that “BioActor will become a center of excellence for innovation and clinical research within Solabia’s nutrition division…”
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.
